- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05621122
Pro-Vegetarian Diets, Microbial/Metabolite Profiles and Cancer (MIVECA)
Characterizacion of Pro-VEgetarian Diets: Diet Quality and Nutrition, MIcrobial/Metabolite Profiles and Implications in CAncer (MIVECA Study)
Study Overview
Status
Intervention / Treatment
Detailed Description
Plant-based foods (fruits, vegetables, cereals, nuts and seeds, legumes, and vegetable oils) are the main source of fiber and other bioactive compounds in the diet. Plant-based diets are therefore assumed to prevent mortality and the ocurrence of chronic diseases including cancer. However, evidence on this issue is still scarce, and the mechanisms and drivers of their potential health benefits are also only partially known.
The main objectices of this project are:
- To develop and validate dietary assessment methods for the vegetarian population
- To assess dietary habits and consumer beliefs of vegetarians with respect to omnivores, considering different types of vegetarian diets
- To identify a gut microbiota signature related to plant-based diets from subgroups of subjects following a plant-based diet foods (vegans, lacto-vegetarians, …, and pro-vegetarians) and omnivorous subjects (non-plant-based diets), from stool metagenomic sequencing.
- To relate this signature with metabolites present in faeces (related to the presence of certain microbial species) and in urine to improve the predictive capacity of the microbial signature of vegetable diets.
- Validate the signature using independent study populations, and including colorectal and breast cancer survivors as another study target.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Esther Molina Montes
- Phone Number: 958240750
- Email: memolina@ugr.es
Study Contact Backup
- Name: Noelia M Rodriguez Martin
- Email: nmrodriguez@ig.csic.es
Study Locations
-
-
-
Barcelona, Spain
- Not yet recruiting
- Idibell Ico
-
Contact:
- Mireia Obon Santacana
-
Sub-Investigator:
- Mireia Obon Santacana
-
Donostia, Spain
- Not yet recruiting
- Biodonostia
-
Contact:
- Pilar Amiano
-
Sub-Investigator:
- Pilar Amiano
-
Granada, Spain
- Recruiting
- University of Granada
-
Contact:
- Esther Molina Montes, Doctor
- Phone Number: 958240750
- Email: memolina@ugr.es
-
Principal Investigator:
- Esther Molina-Montes
-
Sub-Investigator:
- Maria Dolores Ruiz Lopez
-
Sub-Investigator:
- Reyes Artacho
-
Sub-Investigator:
- Belen Garcia-Villanova
-
Sub-Investigator:
- Vito Verardo
-
Sub-Investigator:
- Maria Jose Sanchez Perez
-
Sub-Investigator:
- Miguel Rodriguez Barranco
-
Madrid, Spain
- Not yet recruiting
- Csic-Ictan
-
Contact:
- Beatriz Sarria
-
Sub-Investigator:
- Beatriz Sarria
-
Sevilla, Spain
- Not yet recruiting
- CSIC-IG
-
Contact:
- Noelia M Rodriguez Martin
- Email: nmrodriguez@ig.csic.es
-
Principal Investigator:
- Noelia M Rodriguez-Martin
-
Sub-Investigator:
- Justo J Pedroche Jimenez
-
Sub-Investigator:
- Ana L Lemus-Conejo
-
Sub-Investigator:
- Rocio M Toscano Sanchez
-
Tarragona, Spain
- Not yet recruiting
- IISPV Pere Virgili
-
Contact:
- Raquel Cumeras
-
Sub-Investigator:
- Raquel Cumeras
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
-
Exclusion Criteria:
- pregnancy or lactation
- antibiotic treatment in the previous 2 weeks
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Omnivours
100 subjects (comparison group)
|
This is an observational study.
The control group (omnivours) will be compared with all otgher groups
|
Vegans
50 subjects, adults aged over 18 years, voluntarly participating in this observational study
|
This is an observational study.
The control group (omnivours) will be compared with all otgher groups
|
Lacto-ovo-vegetarians
50 subjects, adults aged over 18 years, voluntarly participating in this observational study
|
This is an observational study.
The control group (omnivours) will be compared with all otgher groups
|
Pesco-vegetarians
50 subjects, adults aged over 18 years, voluntarly participating in this observational study
|
This is an observational study.
The control group (omnivours) will be compared with all otgher groups
|
Pro-vegetarians
50 subjects, adults aged over 18 years, voluntarly participating in this observational study
|
This is an observational study.
The control group (omnivours) will be compared with all otgher groups
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dietary habits obtention from vegetarians: the dietary intake
Time Frame: 3 months
|
Dietary habits will be taken by an online specific Food Frequency Questionnaire (FFQ) for Spanish population, including novel vegetarian foods to evaluate vegetarian food consumption.
The data analysis will be taken at baseline outcome.
|
3 months
|
Dietary assessment validation methods: 24-hour-recalls and dietary intake biomarkers
Time Frame: 6 monts
|
To validated dietary assessment method, two 24-Hour-Recalls in two non-consecutive days will be used, as well as the analysis of specific vegetarian diet metabolites in urine and stool samples using Ultra performance liquid chromatography - tandem mass spectrometer (UPLC-MS/MS).
The data analysis will be taken at baseline.
We have estimated that 200 subjects will be sufficient to detect, with a 95% confidence and power of 90%, correlation coefficients greater than rho=0.2.
|
6 monts
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Esther Molina Montes, Universidad de Granada
- Study Chair: Noelia M Rodriguez, nmrodriguez@ig.csic.es
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PPJIA2021-38
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
University of Michigan Rogel Cancer CenterRecruitingCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
Vanderbilt-Ingram Cancer CenterNational Institutes of Health (NIH)Active, not recruitingAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterHyundai Hope On WheelsRecruitingCancer | Pediatric Cancer | Survivorship | Cancer MetastaticUnited States
-
MiRXES Pte LtdRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Thoracic Cancer | Liver CancerSingapore
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedStage I Breast Cancer | Stage I Uterine Corpus Cancer | Stage II Uterine Corpus Cancer | Stage III Uterine Corpus Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage... and other conditionsUnited States
-
Massachusetts General HospitalNational Comprehensive Cancer NetworkCompletedGastric Cancer | Pancreatic Cancer | Esophageal Cancer | Rectal Cancer | Colon Cancer | Hepatobiliary CancerUnited States
-
Johns Hopkins UniversityNational Cancer Institute (NCI); National Institute on Minority Health and...Enrolling by invitationCancer | Advanced Cancer | End Stage Cancer | MalignancyUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
Case Comprehensive Cancer CenterCompletedStage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Stage IVA Colon Cancer | Stage IVA Rectal Cancer and other conditionsUnited States
Clinical Trials on This is an observational study
-
Asklepios Biopharmaceutical, Inc.RecruitingParkinson's Disease | Multiple System Atrophy | Multiple System Atrophy, Parkinson VariantUnited States, Poland
-
Hadassah Medical OrganizationSuspended
-
Swiss Federal Institute of TechnologyAlzheimer's Drug Discovery FoundationRecruiting
-
Beijing Friendship HospitalRecruitingCognitive Dysfunction | Kidney Failure, Chronic | Magnetic Resonance ImagingChina
-
University Hospital HeidelbergCompletedMucopolysaccharidosis Type I | Mucopolysaccharidosis Type II | Coping Behavior | Mucopolysaccharidosis Type III | Behavior DisordersGermany
-
Linkoeping UniversityCompletedFrailty | Non ST Elevation Myocardial Infarction (NSTEMI)Sweden
-
Isabelle Herter-AeberliBerner FachhochschuleRecruiting
-
Beijing Friendship HospitalRecruitingDiabetes | HemodialysisChina
-
Swiss Federal Institute of TechnologyAlzheimer's Drug Discovery FoundationRecruiting
-
University of LeicesterCompletedAcute Kidney InjuryUnited Kingdom